|
Fruquintinib
- 英文名称：Fruquintinib
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11405
- cas：1194506-26-7
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-04-30
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11405 |
| 用途 | 科研检测 |
| 英文名称 | Fruquintinib |
| 包装规格 | 1MG |
| CAS编号 | 1194506-26-7 |
| 别名 | Fruquintinib |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:98% by HPLC;NMR (Conforms)
分子式:C21H19N3O4
分子量:393.40
溶剂:DMSO (5 mg/ml)
性状:White soliod
存储:-20°C
Activity (short version):VEGFR kinase inhibitor
Function / Pharmacology:Fruquintinib is a potent and highly selective inhibitor of VEGFR kinase (IC50’s: VEGFR1= 33 nM, VEGFR2 = 35 nM, VEGFR3 = 0.5 nM).1 It potently inhibited VEGF/VEGFR signaling and cell proliferation in HUVECs and HLECs and prevented angiogenesis in vitro. Fruquintinib is currently is several clinical trials against metastatic colorectal cancer2 and nonsquamous non-small-cell lung cancer3.
分子式:C21H19N3O4
分子量:393.40
溶剂:DMSO (5 mg/ml)
性状:White soliod
存储:-20°C
Activity (short version):VEGFR kinase inhibitor
Function / Pharmacology:Fruquintinib is a potent and highly selective inhibitor of VEGFR kinase (IC50’s: VEGFR1= 33 nM, VEGFR2 = 35 nM, VEGFR3 = 0.5 nM).1 It potently inhibited VEGF/VEGFR signaling and cell proliferation in HUVECs and HLECs and prevented angiogenesis in vitro. Fruquintinib is currently is several clinical trials against metastatic colorectal cancer2 and nonsquamous non-small-cell lung cancer3.
